PsychedelicNewsBreaks

TuesdayMar 16, 2021 12:02 pm

PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) to Present at Oppenheimer Health Care Conference

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has announced that its Chief Executive Officer, Doug Drysdale, will be presenting a business and pipeline update at the Oppenheimer 31st Annual Healthcare Conference. Drysdale’s presentation is scheduled to begin at 11:20 a.m. Eastern Time on Thursday, March 18, 2021. Interested parties should visit https://ibn.fm/ZE9G5 to register for the event. The presentation will be webcast live at the aforementioned time and available for seven days thereafter via the above link. To view the full press release, visit https://ibn.fm/ZWvHk About Cybin Inc. Cybin is a leading biotechnology company…

Continue Reading

MondayMar 15, 2021 10:10 am

PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) to Present at 2021 Emerging Growth Virtual Conference

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has announced that its Chief Executive Officer, Doug Drysdale, will be presenting a business and pipeline update at the M Vest and Maxim Group 2021 Emerging Growth Virtual Conference slated to take place from March 17-19, 2021. In addition, Drysdale will participate on the psychedelics panel beginning at 3:30 p.m. ET on Wednesday, March 17. Interested parties should visit https://ibn.fm/MjGa2 for more information regarding the event. The panel discussion will be webcast live at the aforementioned time and available for seven days thereafter via the above link. To…

Continue Reading

FridayMar 12, 2021 10:30 am

PsychedelicNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) Releases Refiled Financial Statements, MD&A

Champignon Brands (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) announced that it has refiled its condensed interim consolidated financial statements and management's discussion & analysis ("MD&A") for the three- and six-month periods ended March 31, 2020, following a review by the British Columbia Securities Commission. In its earlier reports of the periods mentioned, Champignon reported intangible assets in connection with its acquisitions of Artisan Growers Ltd., Novo Formulations Ltd. and Tassili Life Sciences Corp. Information regarding those acquisitions have been restated to correct for the accounting of those acquisitions. After review, it was determined that the reported intangible assets did not meet…

Continue Reading

ThursdayMar 11, 2021 10:55 am

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Sells First Batch of Cannabis Oil Extracts to German Pharma Company

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, today announced that it has sold its first shipment of cannabis oil extracts to a German pharmaceutical company. According to the update, Pure Extracts purchased Canadian grown, EU-GMP certified, dry cannabis flower and extracted it into 65% pure THC full spectrum oil (“FSO”) and 85% pure THC distillate. The extracts will be further processed in Germany into an ultra-pure form of THC for medicinal purposes. “It is gratifying to have had our concentrates selected by…

Continue Reading

WednesdayMar 10, 2021 12:51 pm

PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) to Present at Stifel GMP Conference

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today announced that its Chief Executive Officer, Doug Drysdale, will be presenting a business and pipeline update at the Stifel GMP Health Care Conference – Health Care Psychedelics: Addressing the Global Mental Health Crisis. Drysdale’s presentation is scheduled to begin at 1:00 p.m. Eastern Time on Thursday, March 11, 2021. The presentation will be webcast live at https://ibn.fm/yLkYT and available for seven days following the event. To view the full press release, visit https://ibn.fm/Wpble About Cybin Inc. Cybin is a leading biotechnology company focused on progressing psychedelic…

Continue Reading

TuesdayMar 09, 2021 1:17 pm

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Enters Strategic LOI with ShroomBloom

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, today announced that it signed a letter of intent (“LOI”) with ShroomBloom Labs/Floja Bioscience Inc. to enter into an agreement for the supply of psychedelic mushroom biomass. British Columbia-based ShroomBloom is a mushroom cultivator leveraging a unique growing method that uses a sustainable forest product to grow organic Psilocybe Azurescens, also known as Azures, one of the most potent psilocybin mushrooms ever found. Under the terms of the LOI, Pure Extracts would be granted “most…

Continue Reading

MondayMar 08, 2021 10:37 am

PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Commences Trading on the OTCQB(R) Venture Market

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today announced that its shares have commenced trading on the OTCQB(R) Venture Market under the symbol “CLXPF.” “With the commencement of trading on the OTCQB, Cybin has achieved another important milestone on its path to advancing mental health care through evidenced-based therapeutics. This additional capital markets exposure offers us greater visibility within the investment community, which should enhance our liquidity and increase our access to institutional and retail investors,” said Doug Drysdale, CEO of Cybin. “This support is extremely valuable to us as we continue to progress…

Continue Reading

ThursdayMar 04, 2021 10:27 am

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Applies for Health Canada Dealer’s Licence

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, today announced that its wholly owned subsidiary, Pure Mushrooms Corp., has submitted an application to Health Canada for a Dealer’s Licence under the Controlled Drugs and Substances Act (“CDSA”). “We are grateful to have the support of one of Canada’s premiere consulting companies with subject matter proficiency in cannabis and other regulated consumer product industries in assisting that we submitted a fully compliant Dealer’s Licence application to Health Canada,” said Pure Extracts CEO Ben Nikolaevsky.…

Continue Reading

WednesdayMar 03, 2021 10:15 am

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Subsidiary Orders 30,000-Plus Vape Cartridges, Pens for Retail Distribution

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, through its subsidiary Pure Extracts Manufacturing Corp., has ordered more than 30,000 vape cartridges and vape pens. Pure Extracts will fill the cartridges and pens, which are produced by a global manufacturer, with a variety of some of its proprietary, full-spectrum oil (“FSO”) formulations; the company has more than 30 of these exclusive oil formulations. Pure Extracts recently announced a retail distribution agreement, and this order is an indication that the company is preparing to…

Continue Reading

ThursdayFeb 25, 2021 10:41 am

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Announces It Has Submitted Multiple SKUs to Health Canada for Approval

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, has submitted a Notice of New Cannabis Product (“NNCP”) application to Health Canada through its wholly owned subsidiary Pure Extracts Manufacturing Corp. The application requests Health Canada’s approval for more than 20 of Pure Extract’s retail cannabis products including cannabis extracts and edible cannabis such as THC and CBD vapes, and three flavors of gummies. Once approval is received, Pure Extracts anticipates offering the products under its Pure Pulls Vapes and Pure Chews Gummies branded…

Continue Reading